Jupiter Neurosciences Signs Term Sheet For Exclusive U.S. Rights To PharmAla Biotech Holdings MDMA Drug Candidate ALA-002 In Deal Worth Over $100M Including Milestones And Royalties

Benzinga Newsdesk www.benzinga.com Positive 85.3%

Neg 0% Neu 0% Pos 85.3%

Comments

No comments yet. Be the first!